Inpatient continuous glucose monitoring for kids with diabetes
Part of Hormones & metabolism clinical trials.
This study looks at how well a continuous glucose monitor (CGM) called Dexcom G7 works for children with diabetes while they are in the hospital. The goal is to learn more about their blood sugar levels during their stay.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be in the hospital and have diabetes.
- They must use a Dexcom G7 continuous glucose monitor (CGM) with the phone app.
- You agree to share their glucose data with the hospital's database.
- Doctors expect your child to stay in the hospital for at least another day after joining.
- They cannot use a separate Dexcom receiver (only the phone app).
- They cannot take medicines that might mess with the CGM's accuracy (like high doses of acetaminophen).
- They cannot be enrolled in another clinical trial at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is observing how well the Dexcom continuous glucose monitor (CGM) works for people in everyday life over a long period. It aims to understand the real-world benefits and outcomes of using this device to manage blood sugar levels.
This study is a global registry that collects real-world information from people using the Dexcom Continuous Glucose Monitor (CGM). It helps researchers understand how the device works in everyday life, and it may help you manage your blood sugar better.
This study tests if a continuous glucose monitor (CGM) can help guide insulin drip therapy for non-ICU patients who are on steroids and specialized nutrition. It aims to make insulin management easier and more accurate for patients with diabetes or high blood sugar during hospitalization.
This study compares a continuous glucose monitor (CGM) to standard finger-stick blood sugar checks in adults with type 1 diabetes while they are in the hospital and after they go home. It aims to see if using a CGM leads to better blood sugar control during and after hospitalization.
This study tests a continuous glucose monitor (a sensor that tracks glucose) for people with type 1 or type 2 diabetes who receive care at home through Mayo’s Advanced Care at Home program. It may help by improving how safely and accurately blood sugar is followed while you’re at home.
This study tests whether a wearable glucose monitor (Dexcom G7) works well in patients in intensive care after major abdominal surgery or organ transplant who need insulin therapy. The monitor measures blood sugar continuously to help doctors manage insulin doses more safely.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.